Skip to main content
OpenTrials
Completed

NCT Number: NCT01503151

Cognitive Biases Modification Treatment for Social Anxiety

Adults with Social Phobia will be randomly assigned to either an attention bias modification treatment, interpretation bias modification treatment, both, or a placebo control condition not designed to change cognitive bias patterns.

Outcome measures will be social anxiety symptoms and severity as measured by gold standard questionnaires as well as diagnosis of social phobia disorder and symptom counts derived from structured clinical interviews based on DSM-IV criteria.

The investigators expect to find significant reduction in social anxiety symptoms in the Treatment groups relative to the placebo control group. The investigators want to find out the relative efficacy of attention and interpretation oriented treatments and the combination of the two.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Social Phobia Anxiety Disorders Mental Disorders Phobia, Social Phobic Disorders

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Tel-Aviv University

Tel Aviv, Israel

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

People suffering from social anxiety

Exclusion criteria

Pharmacological or Psychological treatment

Treatment and study plan

Attention Bias Modification Treatment (ABMT)

Behavioral

Attention training using a computerized spatial attention task (dot-probe) modified to alter threat-related attention patterns.

Interpretation Bias Modification (IBM)

Behavioral

Interpretive Bias Modification Treatment (IBMT) using a computerized task modified to facilitate a more benign interpretation bias.

Control condition

Behavioral

Attention and interpretation training using a computerized tasks not intended to alter threat-related biases patterns.

Attention and Interpretive biases modification (CBM)

Behavioral

Attention and interpretation training via computerized tasks intended to direct attention away from threat stimuli and to facilitate a more benign interpretation bias.

Primary outcomes

  1. Social Anxiety Scale (LSAS) - diagnostic interview

    Time frame: Expected time frame of 6 weeks per participant. Participants will be assessed before and after the administration of the training/control protocols

    LSAS is a 24-items clinician-administered scale developed for the assessment of fear and avoidance associated with social. The LSAS assesses a wide range of both social interaction and performance/observation situations, which are rated for degree of fear/anxiety and frequency of avoidance.

Secondary outcomes

  1. The Mini International Neuropsychiatric Interview (MINI).

    Time frame: expected time frame of 6 weeks per participant. Participants will be assessed before and after the administration of the training/control protocols

    The Mini International Neuropsychiatric Interview (MINI) is a short diagnostic structured interview (DSI) developed to explore 17 disorders according to Diagnostic and Statistical Manual diagnostic criteria (DSM)

Sponsors and collaborators

Lead sponsor

Tel Aviv University

Other

Registry information

Acronym: CBMSP

Important dates

Study start
2012
Primary completion
2014
Study completion
2014
First posted
Jan 2, 2012
Registry last updated
Dec 2, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.